Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
Morris Sherman(University Health Network), R. Hindes(Bristol-Myers Squibb (United States)), Marcelo José Barbosa Silva(Hospital Universitario Austral), Zachary Goodman(Inova Fairfax Hospital), Richard J. Colonno(Assembly Biosciences (United States)), Jose D. Sollano(University of Santo Tomas), Bruce Kreter(Bristol-Myers Squibb (Germany)), Anna Boroń‐Kaczmarska(Pomeranian Medical University), Cihan Yurdaydın(Ankara University), Paul Martin(University of Bristol), Janusz Cianciara(Medical University of Warsaw), Anne Cross(Bristol-Myers Squibb (United States)), Gail Denisky(Bristol-Myers Squibb (United States)), Yun‐Fan Liaw(Chang Gung Memorial Hospital)
Cited by 414
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Liver biopsy†
|Hepatology|2008|1.9k